Search Results for: Pentaerythritol tetranitrate

May 18, 2019May 18, 2019

Study explores why people at risk for Huntington’s disease choose not to undergo genetic testing

Publication date: May 18, 2019 As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose not to take a gene test that reveals if ... Read more

May 18, 2019May 18, 2019

Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease.

Parkinson's Disease Literature

Publication date: May 16, 2019 We tested in a translational approach the usefulness of plasma creatine kinase (CK) as an objective biomarker for levodopa-induced dyskinesia (LID). Plasma CK levels were ... Read more

May 17, 2019May 17, 2019

Impact of dyskinesia on activities of daily living in Parkinson’s disease: Results from pooled phase 3 ADS-5102 clinical trials.

Parkinson's Disease Literature

Publication date: Mar 01, 2019 In Parkinson’s disease, dyskinesias result from disease progression and chronic levodopa therapy. Using Unified Dyskinesia Rating Scale (UDysRS) data pooled from two pivotal trials of ... Read more

May 17, 2019May 17, 2019

Why adults at risk for Huntington’s choose not to learn if they inherited deadly gene

Huntington's Disease News

Publication date: May 17, 2019 Credit: Wikipedia/ Creative Commons Attribution 3. 0 Unported license As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose ... Read more

May 16, 2019May 16, 2019

-Omics biomarker identification pipeline for translational medicine.

Precision Medicine Literature

Publication date: May 14, 2019 Translational medicine (TM) is an emerging domain that aims to facilitate medical or biological advances efficiently from the scientist to the clinician. Central to the ... Read more

May 16, 2019May 16, 2019

Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson’s disease patients.

Parkinson's Disease Literature

Publication date: May 11, 2019 Parkinson’s disease is the second most common neurodegenerative disease. Lifestyle, environmental effects and several genetic factors have been proposed to contribute to its development. Though ... Read more

May 15, 2019May 15, 2019

Next Generation Networks: Featuring the Potential Role of Emerging Applications in Translational Oncology.

Precision Medicine Literature

Publication date: May 11, 2019 Nowadays, networks are pervasively used as examples of models suitable to mathematically represent and visualize the complexity of systems associated with many diseases, including cancer. ... Read more

May 14, 2019May 14, 2019

Ten Years of Fentanyl-like Drugs: a Technical-analytical Review.

Opioids Literature

Publication date: May 10, 2019 Synthetic opioids, such as fentanyl and its analogues, are a new public health warning. Clandestine laboratories produce drug analogues at a faster rate than these ... Read more

May 12, 2019May 12, 2019

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment.

Huntington's Disease Literature

Publication date: May 10, 2019 Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by the expansion of the CAG repeat in exon 1 of the huntingtin (HTT) gene, which ... Read more

May 12, 2019May 12, 2019

Simultaneous assessment of cell morphology and adhesion using aluminum nanoslit-based plasmonic biosensing chips.

Melanoma Literature

Publication date: May 10, 2019 A variety of physiological and pathological processes rely on cell adhesion, which is most often tracked by changes in cellular morphology. We previously reported a ... Read more